Gabriel Baertschi
Tracked across 1 events · 6 articles · First seen Sep 21, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Grunenthal, a privately held German pharmaceutical company focused on pain management, announced an agreement with Bayer to acquire the cancer treatment Stivarga (regorafenib) for up to 375 million euros. Stivarga is an oral multikinase inhibitor…
Impact: Grunenthal CEO Gabriel Baertschi publicly framed the acquisition as a strong strategic fit and immediately accretive to the business.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Gabriel Baertschi live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard